Real World Data
Collecting,
Real-World.
Data.
From real life care to decision ready Market Access Intelligence—ethically,
compliantly, at global scale
Clinical trials are just one chapter in a medicine’s story. To truly understand its
impact, we must also look at how it performs in the real world. Collecting
Real-World Data (RWD) through a Managed Access Program opens a unique window of
opportunity, especially when medicines are not yet licensed.
Who Benefits
• Pharmaceutical Innovator Companies – Identify early demand before
product launch and sharpen evidence plans.
• Market Access & Consulting Firms – Gain credible inputs for
forecasting, pricing, and policy strategy.
• Regulators & NGOs – Understand therapy gaps and equity issues to
support advocacy and reimbursement frameworks.
• Distributors & Access Programs – Spot new growth markets,
emerging prescriber demand, and unmet needs in real time.
What we offer:-
RWD, Clinical Trials.
Real World Observation:- For unlicensed or early-access therapies, real-world information is limited. Managed/Expanded/Named Patient Programs (where permitted) create the first window to see how a medicine performs in routine care beyond controlled trials—yielding early, pragmatic insights that guide next-step evidence plans.
Access program DNA( expertise): Experience embedding low burden, compliant RWD capture within Managed/Expanded/Named Patient Programs (MAP/EAP/NPP) where permitted.
Therapeutic depth: We work across various therapeutic areas and care settings, adapting to heterogeneous real-world practice patterns.
Reimbursement and Market Strategy: Stakeholders need evidence to optimizes access strategies, drive reimbursement decisions and sharpens launch positioning. RWD informs pricing, access, and market positioning.
Demonstrating Value: RWD illuminates real-life effectiveness, tolerability, and resource use—strengthening value communication to stakeholders.
Analytics & reporting: Expert analysis, tailored dashboards, and milestone reports that translate RWD into clear insights for HEOR, market access, and reimbursement—shared only as aggregated, anonymized intelligence.
How We Support This Journey
Actionable Insights & Compliance First
Actionable Insights: Our analytics team transforms raw entries into clear, strategic reports that support decision-making at critical points in a program.
Compliance First: Every dataset is anonymized, ethically
collected, and aligned with international standards .
Email/WhatsApp: info@ikrispharmanetwork.com
TOLLFREE:
18008891064
